Behavioral health giant Acadia Healthcare Co. Inc. (Nasdaq: ACHC) brought new leadership to its comprehensive treatment centers division.
Dr. Nasser Khan is now operations group president for the division, effective Sept. 6. This division includes 145 centers across the U.S. He reports to John Hollinsworth, Acadia Healthcare’s executive vice president of operations.
The comprehensive treatment center (CTCs) make up about 60% of Acadia Healthcare’s footprint. In total, the company operates 239 behavioral health care facilities, inclusive of over 10,600 beds, in 39 states and Puerto Rico, as of June 30.
Acadia has opened two new CTCs in the first half of the year and intends to open at least six CTCs by the end of the year. It also intends to add 300 new beds to existing facilities, open one wholly-owned facility and two new joint-venture facilities, according to the company’s latest quarterly financial filing with the Securities and Exchange Commission.
Acadia Healthcare is the largest pure-play behavioral health company with about 22,500 employees and a daily patient census of about 70,000 patients.
“Nasser brings unrivaled qualifications to this position. He has successfully managed and grown multi-site, healthcare delivery networks,” Hollinsworth said in a news release. “He understands that our people are our most important asset.”
Before joining Acadia Healthcare, Khan worked as senior vice president of operations at the specialty pharmacy services company and Walgreens Boots Alliance Inc. subsidiary Shields Health Solutions, the release states.
Other executive roles under Khan’s belt include head of program and chief medical officer at Biograph Inc.; division vice president of hospital services for DaVita Inc.; and engagement manager at McKinsey & Co.
“Throughout my career, I have been drawn to areas where I can use my experience and medical expertise for the greatest good,” Khan said in the release. “Working with our exceptional team, my focus will be on supporting our caregivers in delivering compassionate care and driving best-in-class clinical outcomes while expanding our network to help other communities in dire need.”
Acadia Healthcare’s CTCs specialize in medication-assisted treatment (MAT) and behavioral therapy to treat substance-use disorders. They also provide individual and group therapy, intensive outpatient, outpatient and partial hospitalization programs.
Support services include medical care, counseling and education services, the release states.
The company’s new CEO Christopher Hunter said Acadia Healthcare would be a “proactive acquirer” in behavioral health, citing the company’s low debt burden.
Acadia Healthcare brought in about $1.3 billion in the first half of the year.
Companies featured in this article:
